Home Blog Page 638

Tongyu Showcases Integrated Air-Ground-Space Full-Scenario Solutions at MWC 2026, Shaping a Smart and Green Future

BARCELONA, Spain, March 4, 2026 /PRNewswire/ — Tongyu Communication, a global leader in antenna and RF solutions, comprehensively presented its multi-dimensional communication technology innovations covering terrestrial, aerial, and space domains at the 2026 World Mobile Congress (MWC Barcelona) under the theme “Intelligent Connectivity, Greening the Future.”

Tongyu Showcases Integrated Air-Ground-Space Full-Scenario Solutions at MWC 2026, Shaping a Smart and Green Future
Tongyu Showcases Integrated Air-Ground-Space Full-Scenario Solutions at MWC 2026, Shaping a Smart and Green Future

The company highlighted key products and technologies across five focal areas:

Ultra-high-capacity integrated solutions for 5G–A/6G, such as the 6–7GHz 256TR AFU, Hybrid FDD/TDD antennas, 20-Port Luneburg Lens Antennas (2+3 Beams), and Active + Passive 5G+4G Antennas.

Green intelligent solutions for sustainable network evolution, including Intelligent Multi-Sensing Units and Latest Gen4 Taurus Platform.

Customized coverage products for complex environments like tunnels, stadiums, and along railway lines.

Non–terrestrial network (NTN) products that expand connectivity dimensions, covering Ka/Ku–Band Satellite Ground Terminals, Satellite IoT Terminals, and Ground to Airway Coverage Antennas.

Integrated air–ground–space products for seamless global networks, such as QV-band Satellite Payload Reflector Antennas, Ka-band Satellite Payload Antennas, and Ultra-Wideband (Triple-Band) Microwave Antennas.

“We are systematically addressing the core requirements of global network evolution: ultimate performance, green sustainability, and intelligent connectivity,” said Ms. Winnie Wu, Vice President of Tongyu Communication. “Our goal is to provide solutions with outstanding total–cost–of–ownership advantages—progressing from smart terrestrial networks to an integrated air-space architecture—and to collaborate with partners in building a future–ready, multidimensional network ecosystem.”

Welcome to watch the on-site interpretation video posted by Ms. Winnie Wu on LinkedIn for more exciting insights: https://www.linkedin.com/feed/update/urn:li:activity:7434557236724563968

Driven by relentless innovation and a deep understanding of customer challenges, the forward-looking products and solutions showcased by Tongyu Communication are empowering operators and industry clients to construct next-generation networks that are more efficient, intelligent, and sustainable—collectively pushing the frontiers of connectivity.

About Tongyu Communication

Tongyu Communication is a world–leading integrated solutions provider of mobile communication antennas, RF devices, and satellite communication products. The company has long been dedicated to the R&D, production, sales, and service of these technologies. To date, Tongyu holds over 1,100 patents, with its products deployed in more than 100 countries and regions, and over 10 million antennas in operation worldwide.

Airport Dimensions Accelerates Asia-Pacific Expansion with Opening of Blue Sky Premier International Lounge at Surabaya’s Juanda International Airport

SURABAYA, Indonesia, March 4, 2026 /PRNewswire/ — Airport Dimensions, the global leader in airport experiences, is significantly strengthening its footprint across the Asia-Pacific region. Building on a period of rapid growth that includes recent high-profile developments in Hong Kong SAR, Jakarta, and Vietnam, the company today announced the official opening of the Blue Sky Premier Lounge in the International Terminal (T2) at Juanda International Airport, Surabaya.

This opening represents a major milestone in Airport Dimensions’ APAC strategy, following the successful launch of the Blue Sky Premier Lounge at Soekarno-Hatta International Airport in Jakarta. The Jakarta facility has become a benchmark for the partnership between Airport Dimensions and Blue Sky Group, pairing local relevance with world-class hospitality standards to serve Indonesia’s dynamic travel market.

The success of the partnership has been further amplified in Makassar, where the Blue Sky Premier Lounge has achieved more than 3,000 five-star Google reviews since opening last August, demonstrating strong product market fit and a clear understanding of evolving traveller expectations.

The debut of the Blue Sky Premier International Lounge in Surabaya marks the third collaboration between Airport Dimensions and Blue Sky Group. Spanning 462 square meters and accommodating up to 101 guests, the lounge is a sophisticated sanctuary that draws inspiration from Surabaya’s identity as the ‘City of Heroes’. The design narrative seamlessly blends Western influences, characterized by warm woods and muted heritage tones, with the elegant textures of Indonesian tradition, including framed batik that pays homage to the resilience of Kota Pahlawan.

The culinary offering further anchors a strong sense of place, balancing local with international appeal. Guests are invited into a theatre-infused dining experience through interactive live-cooking stations, from made-to-order eggs, pasta, and noodles to a signature steamboat experience that celebrates the communal spirit of Asian dining. Locally rooted flavours take centre stage with icons such as Rawon Surabaya, offering an authentic taste of East Java, alongside the comforting familiarity of the Blue Sky signature mantau, a soft steamed bun reflecting the city’s Chinese-Indonesian culinary heritage. These regional highlights sit comfortably beside recognisable global favourites, ensuring broad appeal for every palate. The experience is completed with premium locally sourced coffee and a professionally tended bar, delivering a refined hospitality journey from arrival through departure.

The lounge is thoughtfully zoned to support both productivity and relaxation. Social spaces such as The Hub form the heart of the experience, offering a wide mix of seating configurations designed to accommodate solo travelers, small groups, and families alike. These flexible seating zones flow naturally into the food and beverage area, encouraging guests to dine, connect, or simply unwind in a lively yet comfortable setting. Complemented by quieter areas such as The Study for focused work or private moments, the lounge delivers a balanced environment that feels both dynamic and spacious, catering seamlessly to business and leisure travelers.

Errol McGlothan, President of Airport Dimensions, EMEA & APAC, commented: “Aviation across Southeast Asia is growing rapidly, with secondary cities like Surabaya playing an increasingly important role in international connectivity. That growth brings a diverse mix of travelers – from early regional departures to long-haul connections, business passengers and families – placing new demands on airport experience. Through our work across Indonesia and the wider Asia-Pacific region, we have seen first-hand how expectations are evolving: people want space to reset, quality food, areas to work, and environments that support every type of journey. This lounge reflects that understanding, responding to how people travel today while delivering the consistent global standards international passengers expect.”

Sucin Rahayu, Director of PT Bumi Liputan Angkasa, Blue Sky Group, added: “At Blue Sky Group, our mission has always been to showcase the very best of Indonesian hospitality to the world. Opening this international lounge in Surabaya alongside Airport Dimensions is a proud moment for us, as it allows us to blend the grit and heritage of this region with world-class service standards. We have poured our local expertise into every detail – from the batik-inspired interiors to the traditional flavours on our menu – to ensure that every guest, whether local or international, leaves with a genuine connection to East Java and a memorable start to their journey.”

Accessing the lounge

The new Blue Sky Premier Lounge is open to all passengers regardless of airline or ticket class, offering a premium experience for every traveler. Access is available to Priority Pass members, the leading airport lounge and travel experiences program, as well as LoungeKey cardholders. Walk in passengers may also enter for a fee of IDR330,000 per person, with additional access available through prebooking via a reservation hotline or participating member partnership programs, subject to availability.

The successful debut in Surabaya serves as a powerful blueprint for Airport Dimensions’ future regional strategy, building on the award-winning launch of the Kyra Lounge at Hong Kong International Airport, named the best Priority Pass lounge in Asia Pacific, and the recent opening of a second Kyra location. This momentum is further mirrored in Vietnam, where the company recently celebrated the unveiling of the upgraded Rose Business Lounge at Tan Son Nhat International Airport in Ho Chi Minh City in partnership with SASCO. Growth in Vietnam is further evidenced with the recent announcement of a new lounge in development at Noi Bai International Airport in Hanoi, to be delivered in collaboration with Vietnam Airport Services Joint Stock Company, Vietnam’s leading airport commercial services provider.

As Airport Dimensions continues to scale its global portfolio of over 85 airport experiences, these strategic milestones across Indonesia, Hong Kong SAR, and Vietnam reinforce its position as a dominant force in the APAC market, with further ambitious regional developments expected to follow.

About Airport Dimensions  

For over two decades, Airport Dimensions has pioneered passenger first experiences, evolving how travelers spend their time and how airports unlock value.

Grounded in insight and a breadth of expertise across lounges, sleep, play, and digital, the company has built a diverse portfolio that creates choice and enjoyment for passengers, amidst ever-evolving expectations.

Airport Dimensions’ deep understanding of airports and a commitment to true partnership help transform space, grow non-aeronautical revenue, and deliver a greater passenger experience.

With a presence in key airports across North America, Latin America, Europe, the Middle East, and Asia Pacific, Airport Dimensions designs and delivers experiences shaped by passenger needs and airport ambitions.

Across its global network, Airport Dimensions partners with over 50 airports and multiple airline partners to deliver award-winning hospitality experiences to millions of travelers. Most recently, No1 Lounge at Heathrow Terminal 2 was voted World’s Leading Airport Lounge 2025 and Europe’s Leading Airport Lounge 2025 at the World Travel Awards; Chase Sapphire Lounge by The Club at LGA received World’s Best Third-Party Lounge 2025 from Business Traveler; Kyra Lounge earned Asia’s Leading Airport Lounge 2025 at the World Travel Awards; and The Club SFO was named Best New Passenger Experience 2025 by ACI.

Airport Dimensions is a Collinson company.    

Gene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026

In Partnership with ATC Genomics, the Company Presented One of Asia’s Largest Real-World Datasets (n=12,281) for AI-Powered Multi-Cancer Early Detection (MCED) and Showcased its Clinically Validated ctDNA-Powered Oncology Portfolio Across the Full Cancer Continuum for High-Risk and Hereditary Populations.

ANTALYA, Türkiye, March 4, 2026 /PRNewswire/ — Gene Solutions announced its strategic entry into the Turkish market at the 2nd International Hereditary Cancers Congress (IHCC), held 05–08 February 2026 in Antalya.

Organized by the Hereditary Cancer Association, IHCC convened medical oncologists, surgical oncologists, clinical geneticists, and laboratory directors to advance evidence-based approaches in hereditary cancer prevention and precision oncology. The 2026 congress brought together over 600 oncology and genetics experts to advance evidence-based hereditary cancer care.

As hereditary cancer care evolves from risk assessment toward earlier detection, personalized surveillance, and preventive precision care, IHCC served as a key platform to discuss the clinical integration of genomic medicine and multidisciplinary models of care.

In collaboration with ATC Genomics Sağlık Teknolojileri A.Ş. (ATC Genomics), a leading Türkiye-based provider and distributor with over 30 years of experience in molecular diagnostics and life sciences—Gene Solutions presented compelling new Real-World Evidence (RWE) from one of the largest Asian cohorts evaluating its MCED assay.(1) Alongside this data, the company showcased its full ctDNA-powered oncology portfolio:

  • SPOT-MAS™: AI-powered Multi-Cancer Early Detection.
  • K-4CARE™: Comprehensive Genomic and Transcriptomic Profiling (CGTP) with longitudinal MRD monitoring.

These multi-omics solutions meet the highest international performance standards, while providing accessible and scalable precision oncology for hereditary and high-risk cohorts across diverse populations.

Industry Satellite Symposium: From Screening to Precision Care
In alignment with this direction, Gene Solutions and ATC Genomics hosted an Industry Satellite Symposium entitled: “From Screening to Precision Care: The ctDNA Continuum in Oncology – Insights for High-Risk and Hereditary Populations.”

From left to right: Prof. Dr. Taha Bahşi, Medical Geneticist and Head of the Genetic Diseases Evaluation Center at Memorial Health Group, Türkiye; Prof. Dr. Mustafa Özdoğan, Medical Oncologist and Head of the Cancer Center at Memorial Health Group, Türkiye; Dr. Le Son Tran, Principal Investigator at Gene Solutions; Dr. Terence Aik Huang Tan, Medical Oncologist at International Cancer Specialists, Singapore and Dr. Duy Sinh Nguyen, Oncology Medical Director at Gene Solutions.
From left to right: Prof. Dr. Taha Bahşi, Medical Geneticist and Head of the Genetic Diseases Evaluation Center at Memorial Health Group, Türkiye; Prof. Dr. Mustafa Özdoğan, Medical Oncologist and Head of the Cancer Center at Memorial Health Group, Türkiye; Dr. Le Son Tran, Principal Investigator at Gene Solutions; Dr. Terence Aik Huang Tan, Medical Oncologist at International Cancer Specialists, Singapore and Dr. Duy Sinh Nguyen, Oncology Medical Director at Gene Solutions.

Co-chaired by Prof. Dr. Mustafa Özdoğan, Medical Oncologist and Head of the Cancer Center at Memorial Health Group, Türkiye and Prof. Dr. Taha Bahşi, Medical Geneticist and Head of the Genetic Diseases Evaluation Center at Memorial Health Group, Türkiye, the program addressed the full ctDNA continuum—delivering actionable evidence from early cancer screening to therapy guidance and longitudinal surveillance—with a focus on hereditary and high-risk populations.

  • Dr. Le Son Tran, Principal Investigator at Gene Solutions, presented “SPOT-MAS: A Multi-Omics Approach to Cancer Detection”.
    He addressed limitations of single-organ screening and highlighted SPOT-MAS technology, including cfDNA multi-omics integration, machine learning, which integrates genetic, epigenetic, and fragmentomic signatures from a single blood draw to detect 10 cancer types and 75 subtypes. In addition, he showcased the K-DETEK prospective study (9,024 asymptomatic individuals), demonstrating 78.1% sensitivity and 99.8% specificity, with AI-driven tissue-of-origin accuracy of 84%, underscoring affordability and scalability for population-level impact in high-risk cohorts.
  • Dr. Duy Sinh Nguyen, Oncology Medical Director at Gene Solutions, presented “Beyond DNA: Integrated Comprehensive Genomic & Transcriptomic Profiling with Longitudinal MRD Monitoring”. 
    He introduced the K-4CARE platform, a unified workflow that integrates genomic and transcriptomic profiling for fusion detection, immune signatures, and therapy selection while also providing personalized ctDNA-MRD status for precise surveillance. The talk covered methodology, analytical/clinical performance, real-world cases, and practical implementation pathways to advance precision treatment.
  • Dr. Terence Aik Huang Tan, Medical Oncologist at International Cancer Specialists, Singapore, presented “Current Clinical Practice and Future Directions of ctDNA-MRD Monitoring”. 
    Offering an independent perspective, he reviewed the current international guideline landscape (including NCCN, ESMO, and JSCO), real-world scenarios from Asia, and highlighted clinical spaces of equipoise in the NCCN guidelines—where ctDNA-MRD can support shared decision-making and guide escalation or de-escalation, with potential to significantly extend median overall survival.

The session concluded with an interactive Q&A moderated by Prof. Dr. Mustafa Özdoğan and Prof. Dr. Taha Bahşi.

Oral Presentation Highlight at IHCC: Large-Scale Real-World Evidence for Multi-Cancer Early Detection in Asia
Dr. Luu Hong Dang Nguyen, Deputy Medical Director at Gene Solutions, presented results from one of the largest RWE datasets in Asia evaluating SPOT-MAS. In a real-world cohort of 12,281 individuals (median age 43 years) enriched for familial cancer risk and followed for 12 months, SPOT-MAS demonstrated sensitivity of 78.2%, specificity of 99.8%, PPV of 67%, NPV of 99.9%, and tumor-of-origin accuracy of 82.0%, consistent with K-DETEK prospective validation.

Dr. Dang Nguyen emphasized the shift toward “cancer interception”—proactive detection and treatment of precancerous lesions to reduce future cancer burden and outlined Gene Solutions’ focus on high-risk genetic and familial cohorts.

Read details on symposium insights and oral presentation: https://genesolutions.com/news/gene-solutions-atc-introducing-oncology-portfolio-in-turkey-at-the-2nd-international-hereditary-cancers-congress-with-industry-symposium-oral-presentation/

Strong Momentum from Turkish Clinicians
“Türkiye serves as a strategic gateway for precision oncology across Europe, Central Asia, the Middle East and Africa. Together with ATC Genomics, we are bringing clinicians accessible, clinically validated ctDNA solutions—from early detection to treatment decision-making and surveillance—that meet the highest international performance standards and are backed by robust RWE,” said Dr. Özgüncem Bozkulak, General Manager, TR-EEMEA-CIS, Gene Solutions. “Our multi-omics platforms and growing clinical evidence base reflect our commitment to improving outcomes for patients with hereditary and high-risk cancer while supporting localized, scalable implementation.”

“We are proud to partner with Gene Solutions to expand access to state-of-the-art liquid biopsy technologies in Türkiye,” said Burcu Torun, Managing Partner and General Manager, ATC Genomics. “This collaboration strengthens our portfolio and supports the Turkish oncology community with end-to-end solutions that can be integrated into daily clinical practice.”

Gene Solutions thanks the Hereditary Cancer Association, congress leadership, speakers, and participants for an impactful scientific exchange and looks forward to contributing to the advancement of precision oncology in Türkiye.

(1) Nguyen, L. H. D., et al. (2025). Prospective validation study: a non-invasive circulating tumor DNA-based assay for simultaneous early detection of multiple cancers in asymptomatic adults. BMC Medicine, 23(1).

About Gene Solutions
Gene Solutions is a global biotechnology company headquartered in Singapore with a mission to make advanced genomic solutions accessible and affordable. Leveraging multi-omics, Next-Generation Sequencing (NGS), and Artificial Intelligence, the company offers a comprehensive portfolio, including next-generation prenatal screening for fetal and maternal health (triSure), multi-cancer early detection (SPOT-MAS), and comprehensive tumor profiling and ctDNA monitoring (K-TRACK, K-4CARE).

Since 2017, Gene Solutions has performed over three million genetic tests worldwide through CAP-accredited laboratories across multiple markets. Through continuous innovation and strategic collaborations, the company is advancing earlier cancer detection, precision care, and reproductive health globally.
Learn more: www.genesolutions.com

About ATC Genomics Türkiye
ATC Genomics Sağlık Teknolojileri A.Ş. (ATC Genomics) is a Türkiye-based provider and distributor in molecular diagnostics and life sciences. Since 1996, ATC has brought advanced genomic technologies, high-quality products, and services to clinicians, scientists, and laboratories—supporting disease prevention, early diagnosis, and personalized treatment decisions through international collaborations and innovation. The company emphasizes human-centred values and quality, serving molecular diagnostic and research laboratories in line with international standards, and highlights its “Trusted Partner in Genomics” ethos on its corporate site.
Learn more: www.atc.com.tr

Media Contact
Gene Solutions
Email: pr@genesolutions.com
ATC Genomics
Email: bilgi@atc.com.tr

Advancing Influenza Vaccine Development: Sino Biological Launches Antigens for the 2026-2027 Northern Hemisphere Influenza Vaccine Strains

HOUSTON, March 4, 2026 /PRNewswire/ — The World Health Organization (WHO) has announced its recommendations for the 2026–2027 Northern Hemisphere influenza vaccine composition, highlighting the continued spread of A(H3N2) subclade K and emerging B/Victoria lineage strains. In rapid response, Sino Biological, Inc. (Shenzhen Stock Exchange: 301047.SZ), a global leader in recombinant technology, has launched the 2026-2027 Northern Hemisphere influenza vaccine strain antigens to accelerate vaccine development.

Decoding the 2026-2027 Northern Hemisphere Influenza Vaccine Strains

Since its identification in August 2025, H3N2 subclade K (J.2.4.1) has become the dominant influenza A strain globally. Defined by the T135K and S144N mutations, this strain exhibits enhanced immune escape, prompting WHO to select A/Darwin/1454/2025 as the new H3N2 reference virus. The H1N1 component has been updated to A/Missouri/11/2025. Meanwhile, B/Victoria lineage activity is rising sharply, with proportions increasing from 6% to over 20% in regions including Hong Kong SAR and the U.S., leading WHO to recommend B/Tokyo/EIS13-175/2025 and B/Pennsylvania/14/2025 strains.

Sino Biological’s Comprehensive Reagents for Influenza Research

To support global influenza vaccine research and development, Sino Biological has launched an extensive portfolio of recombinant antigens for the 2026-2027 influenza vaccine strains, including A/Missouri/11/2025 (H1N1) HA Trimer (purity ≥90% verified by SEC-MALS), NA, and NP proteins. “Our mission is to provide the scientific community with the highest quality tools as rapidly as possible when infectious disease evolution threatens global health preparedness,” said Dr. Rob Burgess, Chief Business Officer at Sino Biological US.

About Sino Biological

Sino Biological is a global biotechnology company specializing in high-quality recombinant proteins, antibodies, and customized research services. Serving researchers in more than 90 countries, Sino Biological supports basic research, drug discovery, vaccine development, and diagnostics through its comprehensive product portfolio, proprietary quality systems, and innovative research platforms.

Forward-Looking Statements

Certain statements in this document are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act. These statements are based on Sino Biological management’s current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from those included in these statements due to a variety of factors, over which Sino Biological has no control. Sino Biological assumes no obligation to update these forward-looking statements and does not intend to do so.

For media inquiries or partnership opportunities, please contact:

Sino Biological, Inc.
gmo@sinobiological.cn
www.sinobiological.com

PROTECTHEALTH STRENGTHENS GOVERNANCE AND SERVICE CONTINUITY WITH ISO 22301 BCMS CERTIFICATION

CYBERJAYA, Malaysia, March 4, 2026 /PRNewswire/ — ProtectHealth Corporation Sdn. Bhd. has reinforced its role as a key government agency and strategic purchaser of healthcare services with the successful attainment of the ISO 22301:2019/AMD1:2024 Business Continuity Management System (BCMS) Certification.

ProtectHealth Corporation Sdn. Bhd. Chief Executive Officer, Wan Mohd Hazwan Wan Mohd Najib (right) receiving the ISO 22301 Business Continuity Management System (BCMS) Certification from CyberSecurity Malaysia Acting Chief Executive Officer, Roshdi Hj Ahmad (left), underscoring ProtectHealth’s commitment to strengthening business continuity and organisational resilience.
ProtectHealth Corporation Sdn. Bhd. Chief Executive Officer, Wan Mohd Hazwan Wan Mohd Najib (right) receiving the ISO 22301 Business Continuity Management System (BCMS) Certification from CyberSecurity Malaysia Acting Chief Executive Officer, Roshdi Hj Ahmad (left), underscoring ProtectHealth’s commitment to strengthening business continuity and organisational resilience.

The certification reflects ProtectHealth’s commitment to strong governance and operational resilience, ensuring the continuity of critical healthcare financing initiatives and public-private partnerships. It underscores the organisation’s responsibility to deliver reliable, accessible and uninterrupted healthcare services to beneficiaries nationwide.

The certified BCMS supports the sustained delivery of ProtectHealth managed initiatives, including PeKa B40, Skim Perubatan MADANI, Skim Perlindungan Insurans Kesihatan Pekerja Asing (SPIKPA) and the Hospital Services Outsourcing Programme (HSOP), by safeguarding core operational, financial and coordination functions.

ProtectHealth Corporation’s Chief Executive Officer, Wan Mohd Hazwan Wan Mohd Najib, said the certification demonstrates the organisation’s preparedness in managing disruptions while maintaining service continuity.

“This certification demonstrates our commitment to stakeholders by ensuring that robust systems are in place to protect operations, manage risks effectively and enable swift recovery, so that essential services continue without disruption,” he said.

CyberSecurity Malaysia’s Acting Chief Executive Officer, Roshdi Hj Ahmad, said the achievement reflects ProtectHealth’s proactive approach in embedding business continuity as a core organisational capability.

“Business continuity is a key element of good governance. This certification reflects ProtectHealth’s strong leadership in safeguarding the continuous delivery of critical healthcare services, protecting public resources and strengthening institutional resilience,” he said.

The BCMS certification journey commenced on 17 April 2025, with ProtectHealth successfully fulfilling all certification requirements in less than one year, positioning the organisation among entities that have achieved certification within a notably efficient timeframe.

In line with its continuous improvement agenda, ProtectHealth is also preparing to pursue ISO/IEC 27001 Information Security Management System (ISMS) certification, further strengthening information security governance in alignment with internationally recognised standards.

PROTECTHEALTH CORPORATION SDN. BHD.

About ProtectHealth Corporation Sdn. Bhd.

ProtectHealth Corporation Sdn. Bhd. (ProtectHealth), incorporated on 19 December 2016, is a wholly owned subsidiary of ProtectHealth Malaysia, established under the Ministry of Health Malaysia (MOH). As a not-for-profit company, ProtectHealth is mandated to coordinate, administer, and manage healthcare-related initiatives focusing on sustainable health financing and equitable access to care.

ProtectHealth serves as the scheme administrator for the Skim Perubatan MADANI, Skim Peduli Kesihatan untuk Kumpulan B40 (PeKa B40), and the Hospital Services Outsourcing Programme (HSOP). The company also acts as the electronic service provider (ESP) for the Skim Perlindungan Insurans Kesihatan Pekerja Asing (SPIKPA) and was the key implementer for private medical practitioner and healthcare NGO participation in the National COVID-19 Immunisation Programme (PICK).

Arduino and Qualcomm Launch Hackster’s First Developer Contest of 2026 Global Competition Kicks Off With 300 Arduino UNO Q Boards and Opportunities to Showcase Edge AI Innovation

SAN DIEGO, March 3, 2026 /PRNewswire/ — Arduino and Qualcomm Technologies, Inc. have announced the launch of Hackster’s first global developer contest of 2026, inviting engineers, makers, and innovators worldwide to build groundbreaking projects using the newly introduced Arduino® UNO™ Q platform.

The competition is hosted on Hackster.io and is supported by a strong ecosystem of technology partners, with the goal of accelerating innovation in AI, IoT, robotics, and edge computing. The contest empowers developers to turn bold ideas into real-world solutions that demonstrate the future of connected intelligence.

To support participation, the organizers will give away 300 Arduino UNO Q boards, enabling developers to prototype, experiment, and deploy their ideas on cutting-edge hardware.

At the heart of the competition is the Arduino UNO Q, a hybrid platform that combines a Qualcomm Dragonwing™ QRB2210 MPU running Linux with an STM32 microcontroller for real-time control. This dual-architecture design enables developers to build sophisticated applications that blend AI inference, real-time processing, and cloud connectivity.

Participants will develop using Arduino® App Lab, which allows seamless integration of Arduino sketches, Python applications, and AI models within a single workflow. Native support for machine learning at the edge—including computer vision and audio AI—makes the UNO Q especially well-suited for on-device intelligence.

The board also offers rich connectivity and expandability, including Wi-Fi 5, Bluetooth® 5.1, HDMI, USB-C, camera and display connectors, classic Arduino headers, and Qwiic support, enabling rapid prototyping across a wide range of use cases.

The contest is open to developers of all experience levels, from students and hobbyists to professional engineers. Participants are encouraged to submit projects addressing real-world challenges across multiple domains, including industrial IoT, home automation, robotics, gaming, and social impact.

Projects will be evaluated on innovation, technical execution, user experience, sustainability, and scalability, encouraging participants to think beyond prototypes and toward deployable solutions.

How to Participate

Developers can join the contest by registering on Hackster.io. Winning teams and individuals will receive cash prizes, global visibility on Hackster.io, and industry recognition. The Best in Show award includes a paid trip to Maker Faire Rome 2026, where winners will showcase their projects to an international audience of makers, engineers, and technology leaders.

For more information, please refer to our official press release here.

Cardumen Capital Strengthens Global Reach Through Its Taipei-Based APAC Partner Following NVIDIA’s Acquisition of Its Portfolio Company Illumex

Building on the acquisition of Illumex by NVIDIA, the firm validates its Seed-to-Exit thesis and reinforces its mission to bridge Asian capital with world-class DeepTech.


TAIPEI, TAIWAN – Media OutReach Newswire – 4 March 2026 – Cardumen Capital, a leading European DeepTech venture capital firm, today marks a pivotal milestone in its international momentum following the acquisition of its portfolio company, Illumex, by NVIDIA. This landmark exit further solidifies the firm’s strategic presence in the Asia-Pacific region and cements its 2019 vintage fund’s position as a leading performer within its vintage cohort.

A Seed-to-Exit Success Story

Cardumen Capital was Illumex’s first investor and led its 2021 seed round, supporting the company from inception through to exit. General Partners Gonzalo Martínez de Azagra and Igor de la Sota identified the startup’s potential at the seed stage, guiding it toward this landmark milestone.

“This acquisition validates our DeepTech thesis,” said Gonzalo Martínez de Azagra. “By backing visionary founders early, we demonstrate our ability to identify the core building blocks of the AI era.”

Igor de la Sota added: “The success of the Illumex exit underscores the global demand for robust data infrastructure in the age of Generative AI. We are proud to have supported the team from day one in building a platform that now sits at the heart of the world’s AI computing network.”

Strengthening the Bridge to Asia-Pacific

Illumex joining NVIDIA serves as a powerful catalyst for Cardumen Capital’s mission in Asia. Led by Taipei-based APAC Venture Partner Stan Yu, a serial entrepreneur turned venture capitalist, the firm is intensifying its efforts to bridge Asian strategic capital with world-class innovation hubs in Europe, Israel, and global DeepTech ecosystems.

“Building on this milestone exit to NVIDIA, we are seeing unprecedented momentum for our strategy in the APAC region,” said Stan Yu. “The journey of Illumex proves the caliber of opportunities we bring to our partners. From our base in Asia, we are uniquely positioned to facilitate these high-stakes connections, ensuring that Asian institutional capital has exclusive access to the next wave of transformative DeepTech and frontier innovations.”

As a pioneering venture capital firm with a dedicated partner presence in Taipei bridging the EMEA tech ecosystem, Cardumen Capital is uniquely positioned to drive cross-border synergies and deliver the performance expected by the institutional investment landscape in Asia.

Hashtag: #CardumenCapital #Illumex #NVIDIA #DeepTech #AI #VentureCapital #M&A #Taiwan


The issuer is solely responsible for the content of this announcement.

About Cardumen Capital

Cardumen Capital, a leading global venture capital firm supervised by the CNMV (Spanish Securities Market Commission), was founded in 2018 by Gonzalo Martínez de Azagra and Igor de la Sota. With over 15 years of investment experience and a presence across Europe, the Middle East, and Asia, the firm specializes in investing in private market companies and funds, supporting innovation, disruptive technologies, and long-term value creation.

Backed by leading institutional investors, corporations, and family offices, Cardumen Capital focuses on generating sustainable long-term returns through its specialized DeepTech investment strategies and a demonstrated track record of connecting strategic capital with the global innovation frontier.

Gartner® Recognizes OpenWay Group in the 2026 Market Guide for Digital Commerce Payment Platforms

MONT-SAINT-GUILBERT, Belgium, March 4, 2026 /PRNewswire/ — OpenWay is included in the 2026 Gartner Market Guide for Digital Commerce Payment Platforms.

Gartner® Recognizes OpenWay Group in the 2026 Market Guide for Digital Payment Platforms
Gartner® Recognizes OpenWay Group in the 2026 Market Guide for Digital Payment Platforms

As noted by Gartner, “Digital commerce leaders responsible for online and mobile payments should use this Market Guide to understand this complex, rapidly evolving market, as well as the related vendor platform landscape.”

In the report, Gartner identified OpenWay as a Representative Vendor for its product, the Way4 Merchant Acquiring platform.

The report states that the digital commerce payment market remains complex and dynamic. While certain segments such as wholesale processing, hosted payment pages, and tokenization have reached maturity, the market continues to evolve. Gartner notes that the global retail e-commerce market is projected to grow at a compound annual growth rate of 6.3 % from 2025 to 2030, reaching a market size of $4,964 trillion dollars by 2030 up from $3,660 trillion in 2025. In this context, Gartner recommends that organizations treat payments as a strategic business function and select vendors that provide opportunities to increase revenue and profit through value-added services that allow them to manage the payment experience and optimize acceptance rates. They should ensure that the business’ current and future payment strategy can be supported by the selected vendor by validating market support, payment methods and services the business requires. Moreover, geographic expansion plans that impact payments for the next three to five years are recommended to be included in that strategy.

Way4 is a platform that supports diverse payment scenarios across digital commerce ecosystems.

Way4 Merchant Acquiring is a full-stack digital payment software platform used by leading global banks, top-tier acquirers, payment processors, PayFacs, PSPs, retailers, and fintechs. It supports all merchant categories and sizes, multiple business models, and both card and non-card payments, including digital currencies, wallets, and quasi-money instruments such as fuel liters, airtime, or sustainability points. Built as a configurable omnichannel real-time platform, Way4 enables large acquirers to launch new payment solutions within months and introduce new products or pricing models within weeks while maintaining high availability for large-scale cross-border portfolios of up to 2 million merchants.

We believe OpenWay’s inclusion reflects Gartner’s identification of vendors that meet these criteria within the Market Guide’s defined scope.

Gartner Disclaimer
Gartner, Market Guide for Digital Commerce Payment Platforms, Debbie Buckland, Peter Ryan, 12 January 2026

GARTNER is a trademark of Gartner, Inc. and/or its affiliates. Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.